Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum

Journal of Neurochemistry

Volumn 87, Issue 1, 2003, Pages 107-118

  Chartoff, Elena H ^a   Papadopoulou, Maria ^a   Konradi, Christine ^a   Carlezon Jr , William A ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

C fos; CREB; Naloxone; Nucleus accumbens; Primary cell culture; SKF 82958

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DOPAMINE 1 RECEPTOR STIMULATING AGENT; MORPHINE; NALOXONE; PROTEIN C FOS; RNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; EMBRYO; GENE EXPRESSION; IN VIVO STUDY; MORPHINE ADDICTION; NERVE CELL CULTURE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WITHDRAWAL SYNDROME;

ANIMALS; CELLS, CULTURED; CORPUS STRIATUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINE AGONISTS; ENZYME INHIBITORS; FORSKOLIN; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0141531989     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01992.x     Document Type: Article

References (60)

1. Andersen S. L., Arvanitogiannis A., Pliakas A. M., LeBlanc C. and Carlezon W. A. Jr (2002) Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat. Neurosci. 5, 13-14.
2. Barrot M., Olivier J. D., Perrotti L. I., DiLeone R. J., Berton O., Eisch A. J., Impey S., Storm D. R., Neve R. L., Yin J. C., Zachariou V. and Nestler E. J. (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl Acad. Sci. USA 99, 11435-11440.
3. Bonci A. and Williams J. T. (1997) Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17, 796-803.
4. Bozarth M. A. and Wise R. A. (1983) Neural substrates of opiate reinforcement. Prog. Neuro-Psychopharmacol. Biol Psychiatry 7, 569-575.
5. Carlezon W. A. Jr, Thome J., Olson V. G., Lane-Ladd S. B., Brodkin E. S., Hiroi N., Duman R. S., Neve R. L. and Nestler E. J. (1998) Regulation of cocaine reward by CREB. Science 282, 2272-2275.
6. Childers S. R. (1991) Opioid receptor-coupled second messenger systems. Life Sci. 48, 1991-2003.
7. Cole R. L., Konradi C., Douglass J. and Hyman S. E. (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14, 813-823.
8. De Vries T. J. and Shippenberg, T. S. (2002)-Neural systems underlying opiate addiction. J. Neurosci. 22, 3321-3325.
9. Diana M., Pistis M., Muntoni A. and Gessa G. (1995) Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272, 781-785.
10. Duman R. S., Tallman J. F. and Nestler E. J. (1988) Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246, 1033-1039.
11. Georges F., Stinus L., Bloch B. and Le Moine C. (1999) Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur. J. Neurosci. 11, 481-490.
12. Gilliss B., Malanga C. J., Pieper J. O. and Carlezon W. A. Jr (2002) Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psychopharmacology (Berl) 163, 238-248.
13. Gracy K. N., Dankiewicz L. A. and Koob G. F. (2001) Opiate withdrawal-induced los immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24, 152-160.
14. Greengard P., Jen J., Naim A. C. and Stevens C. F. (1991) Enhancement of the glutamate response by cAMP-dependent protein kinase in hippocampal neurons. Science 253, 1135-1138.
15. Greengard P., Allen P. B. and Naim A. C. (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23, 435-447.
16. Guitart X., Thompson M. A., Mirante C. K., Greenberg M. E. and Nestler E. J. (1992) Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58, 1168-1171.
17. 2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371, 155-157.
18. Hope B. T., Nye H. E., Kelz M. B., Self D. W., Iadarola M. J., Nakabeppu Y., Duman R. S. and Nestler E. J. (1994) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13, 1235-1244.
19. Johnson S. W. and North R. A. (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483-488.
20. Konradi C., Leveque J. C. and Hyman S. E. (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16, 4231-4239.
21. Konradi C., Cole R. L., Heckers S. and Hyman S. E. (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14, 5623-5634.
22. Koob G. F., Stinus L., Le Moal M. and Bloom F. E. (1989a) Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci. Biobehav. Rev. 13, 135-140.
23. Koob G. F., Wall T. L. and Bloom F. E. (1989b) Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacologia 98, 530-534.
24. Koob G. F., Maldonado R. and Stinus L. (1992) Neural substrates of opiate withdrawal. Trends Neurosci. 15, 186-191.
25. Kornhauser J. M., Cowan C. W., Shaywitz A. J., Dolmetsch R. E., Griffith E. C., Hu L. S., Haddad C., Xia Z. and Greenberg M. E. (2002) CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation events. Neuron 34, 221-233.
26. Leveque J. C., Macias W., Rajadhyaksha A., Carlson R. R., Barczak A., Kang S., Li X. M., Coyle J. T., Huganir R. L., Heckers S. and Konradi C. (2000) Intracellular modulation of NMDA receptor function by antipsychotic drugs. J. Neurosci. 20, 4011-4020.
27. Lonze B. E. and Ginty D. D. (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623.
28. Maldonado R., Stinus L., Gold L. H. and Koob G. F. (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261, 669-677.
29. Maldonado R., Blendy J. A., Tzavara E., Gass P., Roques B. P., Hanoune J. and Schutz G. (1996) Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273, 657-659.
30. Mansour A., Fox C. A., Burke S., Akil H. and Watson S. J. (1995) Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8, 283-305.
31. Nestler E. J. (1992) Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450.
32. Nestler E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128.
33. Nestler E. J. and Aghajanian G. K. (1997) Molecular and cellular basis of addiction. Science 278, 58-63.
34. Nestler E. J. and Tallman J. F. (1988) Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33, 127-132.
35. Nye H. E. and Nestler E. J. (1996) Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636-645.
36. Olds M. E. (1982) Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237, 429-440.
37. Pliakas A. M., Carlson R. R., Neve R. L., Konradi C., Nestler E. J. and Carlezon W. A. Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci. 21, 7397-7403.
38. Rada P. V., Mark G. P., Taylor K. M. and Hoebel B. G. (1996) Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacol. Biochem Behav. 53, 809-816.
39. Rajadhyaksha A., Barczak A., Macias W., Leveque J. C., Lewis S. E. and Konradi C. (1999) L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J. Neurosci. 19, 6348-6359.
40. Rasmussen K., Beitner-Johnson D. B., Krystal J. H., Aghajanian G. K. and Nestler E. J. (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10, 2308-2317.
41. Rossetti Z. L., Hmaidan Y. and Gessa G. L. (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221, 227-234.
42. Sassone-Corsi P., Visvader J., Ferland L., Mellon P. L. and Verma I. M. (1988) Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 2, 1529-1538.
43. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582, 349-352.
44. Self D. W., McClenahan A. W., Beimer-Johnson D., Terwilliger R. Z. and Nestler E. J. (1995) Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21, 312-318.
45. Self D. W., Genova L. M., Hope B. T., Barnhart W. J., Spencer J. J. and Nestler E. J. (1998) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18, 1848-1859.
46. Sharma S. K., Klee W. A. and Nirenberg M. (1975a) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl Acad. Sci. USA 72, 3092-3096.
47. Sharma S. K., Nirenberg M. and Klee W. A. (1975b) Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 72, 590-594.
48. Shaw-Lutchman T. Z., Barrot M., Wallace T, Gilden L., Zachariou V., Impey S., Duman R. S., Storm D. and Nestler E. J. (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 22, 3663-3672.
49. 1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Brain Res. 436, 169-172.
50. Terwilliger R. Z., Beimer-Johnson D., Sevarino K. A., Crain S. M. and Nestler E. J. (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548, 100-110.
51. Tjon Tien Ril H. K., De Vries T. J., Wardeh G., Hogenboom F., Mulder A. H. and Schoffelmeer A. N. (1993) Long-lasting reciprocal changes in striatal dopamine and acetylcholine release upon morphine withdrawal. Eur. J. Pharmacol 235, 321-322.
52. Van Vliet B. J., De Vries T J., Wardeh G., Mulder A. H. and Schoffelmeer A. N. (1991) mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure. Eur. J. Pharmacol. 208, 105-111.
53. Vaysse P. J., Zukin R. S., Fields K. L. and Kessler J. A. (1990) Characterization of opioid receptors in cultured neurons. J. Neurochem. 55, 624-631.
54. Walters C. L. and Blendy J. A. (2001) Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J. Neurosci. 21, 9438-9444.
55. Watts V. J. (2002) Molecular mechanisms, for heterologous sensitization of adenylate cyclase. J. Pharmacol. Exp. Ther. 302, 1-7.
56. Widnell K. L., Russell D. S. and Nestler E. J. (1994) Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc. Natl Acad. Sci. USA 91, 10947-10951.
57. Widnell K. L., Self D. W., Lane S. B., Russell D. S., Vaidya V. A., Miserendino M. J., Rubin C. S., Duman R. S. and Nestler E. J. (1996) Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276, 306-315.
58. Wise R. A. (1989) Opiate reward: sites and substrates. Neurosci. Biobehav. Rev. 13, 129-133.
59. Wise R. A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243-251.
60. 2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro. Neuroscience 89, 221-233.